Gastrointestinal bleeding: From overt to obscure

Endoscopy

Volumn 38, Issue 2, 2006, Pages 116-121

  Bhasin, D K ^a   Rana, S S ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NADOLOL; OMEPRAZOLE; PLACEBO; PROPRANOLOL; PROTHROMBIN; RANITIDINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SOMATOSTATIN;

ARTICLE; CAPSULE ENDOSCOPY; CLINICAL TRIAL; CLIP; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES BLEEDING; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; LIGATION; LIVER CIRRHOSIS; LIVER FAILURE; PEPTIC ULCER BLEEDING; PORTAL HYPERTENSION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SIDE EFFECT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HEMOSTATICS; HUMANS;

EID: 33344477161     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-921195     Document Type: Article

References (21)

1. Bosch J, Thabut D, Bendtsen F et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double blind trial. Gastroenterology 2004; 127: 1123-1130
2. Ejlersen E, Melsen T, Ingerslev J et al. Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from esophageal varices. Scand J Gastroenterol 2001; 36: 1081-1085
3. Romero-Castro R, Jiménez-Sáenz M, Pellicer-Bautista F et al. Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices. Clin Gastroenterol Hepatol 2004; 2: 78-84
4. Pavese P, Bonadona A, Beaubien J et al. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases. Can J Anesth 2005; 52: 26-29
5. Atkison PR, Jardine L, Williams S et al. Use of recombinant factor VIIa in pediatric patients with liver failure and severe coagulopathy. Transplant Proc 2005; 37: 1091-1093
6. Levi M, Peters M, Buller HR. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit Care Med 2005; 33: 883-890
7. De la Pena J, Brullet E, Sanchez-Hernandez E et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 2005; 41: 572-578
8. Lo GH, Lai KH, Cheng JS et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective randomized trial. Hepatology 2000; 32: 461-465
9. Sarin SK, Wadhawan M, Agarwal SR et al. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol 2005; 100: 797-804
10. Lo GH, Chen WC, Chen MH et al. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc 2004; 59: 333-338
11. Merkel C, Marin R, Angeli P et al. A placebo controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 2004; 127: 476-484
12. Mata A, Bordas JM, Feu F et al. Wireless capsule endoscopy in patients with obscure gastrointestinal bleeding: a comparative study with push enteroscopy. Aliment Pharmacol Ther 2004; 20: 189-194
13. Selby W. Can clinical features predict the likelihood of finding abnormalities when using capsule endoscopy in patients with GI bleeding of obscure origin? Gastrointest Endosc 2004; 59: 782-787
14. Jones BH, Fleischer DE, Sharma VK et al. Yield of repeat wireless video capsule endoscopy in patients with obscure gastrointestinal bleeding. Am J Gastroenterol 2005; 100: 1058-1064
15. Yamamoto H, Kita H, Sunada K et al. Clinical outcomes of double balloon endoscopy for the diagnosis and treatment of small intestinal diseases. Clin Gastroenterol Hepatol 2004; 2: 1010-1016
16. Matsumoto T, Esaki M, Moriyama T et al. Comparison of capsule endoscopy and enteroscopy with the double-balloon method in patients with obscure bleeding and polyposis. Endoscopy 2005; 37: 827-832
17. Park CH, Lee SJ, Park JH et al. Optimal injection volume of epinephrine for endoscopic prevention of recurrent peptic ulcer bleeding. Gastrointest Endosc 2004; 60: 875-880
18. Park CH, Joo YE, Kim HS et al. A prospective randomized trial comparing mechanical methods of hemostasis plus epinephrine injection to epinephrine injection alone for bleeding peptic ulcer. Gastrointest Endosc 2004; 60: 173-179
19. Bianco MA, Rotondano G, Marmo R et al. Combined epinephrine and bipolar coagulation vs. bipolar probe coagulation alone for bleeding peptic ulcer: a randomized, controlled trial. Gastrointest Endosc 2004; 60: 910-915
20. Thomopoulos KC, Theocharis GJ, Vagenas KA et al. Predictors of hemostatic failure after adrenaline injection in patients with peptic ulcers with non-bleeding visible vessel. Scand J Gastroenterol 2004; 39: 600-604
21. Amano Y, Moriyama N, Suetsugu H et al. Which type of non-bleeding visible vessels in gastric peptic ulcers should be treated by endoscopic hemostasis? J Gastroenterol Hepatol 2004; 19: 13-17